Published in Eur J Neurosci on May 01, 2003
Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther (2007) 2.51
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) (2010) 2.19
The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.83
Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biol Psychiatry (2010) 1.56
Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci U S A (2006) 1.37
kappa-Opioid receptor signaling and brain reward function. Brain Res Rev (2009) 1.32
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci (2012) 1.29
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward. Neuron (2015) 1.02
Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology (2008) 1.01
Bidirectional translational research: Progress in understanding addictive diseases. Neuropharmacology (2008) 0.99
Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction. Biol Psychiatry (2013) 0.90
Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Mol Psychiatry (2012) 0.87
Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study. PLoS One (2012) 0.84
Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence. Front Psychiatry (2013) 0.84
Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area. Neuroscience (2010) 0.82
Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. Adv Pharmacol (2014) 0.81
Genetic identity of thermosensory relay neurons in the lateral parabrachial nucleus. Am J Physiol Regul Integr Comp Physiol (2015) 0.80
Chronic escalating cocaine exposure, abstinence/withdrawal, and chronic re-exposure: effects on striatal dopamine and opioid systems in C57BL/6J mice. Neuropharmacology (2012) 0.80
Transcriptional correlates of human substance use. Ann N Y Acad Sci (2008) 0.80
Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex. Brain Struct Funct (2013) 0.79
Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription. Neuroscience (2012) 0.78
Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol (2015) 0.78
Chronic cocaine exposure induces putamen glutamate and glutamine metabolite abnormalities in squirrel monkeys. Psychopharmacology (Berl) (2011) 0.78
Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects. Pharmacol Biochem Behav (2011) 0.78
Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice. Neuropharmacology (2012) 0.77
Insights from Preclinical Choice Models on Treating Drug Addiction. Trends Pharmacol Sci (2016) 0.76
Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration. Brain Res (2015) 0.76
The opioid receptors as targets for drug abuse medication. Br J Pharmacol (2015) 0.75
Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology (2016) 0.75
A Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. Neuropsychopharmacology (2016) 0.75
"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats". Psychopharmacology (Berl) (2017) 0.75
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Chloramphenicol resistance in the typhoid bacillus. Br Med J (1972) 3.79
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Molecular studies of an fi+ plasmid from strains of Salmonella typhimurium. Mol Gen Genet (1973) 3.05
Application of agarose gel electrophoresis to the characterization of plasmid DNA in drug-resistant enterobacteria. J Gen Microbiol (1979) 3.02
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Mutagenesis of plasmid DNA with hydroxylamine: isolation of mutants of multi-copy plasmids. Mol Gen Genet (1976) 2.92
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test. Infect Immun (1991) 2.35
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Genetic and molecular characterisation of some non-transferring plasmids. Mol Gen Genet (1974) 2.16
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A (1991) 2.04
Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann Intern Med (2000) 2.01
Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys. J Comp Neurol (1981) 2.00
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol (1985) 1.86
Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol Cell Probes (1991) 1.86
Interactions of group H resistance factors with the F factor. J Bacteriol (1973) 1.85
Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification. J Infect Dis (1990) 1.84
Induction and maintenance of ethanol self-administration in cynomolgus monkeys (Macaca fascicularis): long-term characterization of sex and individual differences. Alcohol Clin Exp Res (2001) 1.84
cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol (1991) 1.82
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.78
Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg Infect Dis (1997) 1.75
Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin. J Bacteriol (1980) 1.75
Identification of enteropathogenic Escherichia coli isolated in Britain as enteroaggregative or as members of a subclass of attaching-and-effacing E. coli not hybridising with the EPEC adherence-factor probe. J Med Microbiol (1991) 1.73
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage. Lancet (1983) 1.73
Mapping of a plasmid, coding for colonization, factor antigen I and heat-stable enterotoxin production, isolated from an enterotoxigenic strain of Escherichia coli. J Bacteriol (1982) 1.73
Fertility inhibition in strains of Salmonella typhimurium. Mol Gen Genet (1972) 1.69
Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties. Infect Immun (1981) 1.68
Genetic control and properties of coli surface antigens of colonization factor antigen IV (PCF8775) of enterotoxigenic Escherichia coli. Infect Immun (1988) 1.67
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect (1988) 1.66
Expression of CFA/I fimbriae is positively regulated. Microb Pathog (1990) 1.65
Autoimmunity--a perspective. Annu Rev Immunol (1983) 1.62
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 1.57
Hybridization of strains of Escherichia coli O157 with probes derived from the eaeA gene of enteropathogenic E. coli and the eaeA homolog from a Vero cytotoxin-producing strain of E. coli O157. J Clin Microbiol (1994) 1.57
The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157. Epidemiol Infect (1988) 1.54
Expression of plasmids coding for colonization factor antigen II (CFA/II) and enterotoxin production in Escherichia coli. J Gen Microbiol (1983) 1.53
The value of plasmid studies in the epidemiology of infections due to drug-resistant Salmonella wien. J Infect Dis (1979) 1.52
Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect (1989) 1.50
Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157. J Clin Microbiol (1993) 1.48
Plasmids that code for production of colonization factor antigen II and enterotoxin production in strains of Escherichia coli. Infect Immun (1983) 1.46
Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157. Lancet (1984) 1.46
Comparison of Vero-cytotoxin-encoding phages from Escherichia coli of human and bovine origin. J Gen Microbiol (1989) 1.45
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes. J Infect Dis (1998) 1.39
CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol (1987) 1.38
Glove-related hand urticaria in the absence of Type I latex allergy. Contact Dermatitis (1999) 1.38
Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci (1996) 1.37
Plasmids coding for heat-labile enterotoxin production isolated from Escherichia coli O78: comparison of properties. J Bacteriol (1980) 1.37
Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J Med Microbiol (2001) 1.36
Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect (1996) 1.35
Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J Med Microbiol (2003) 1.31
Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab (2000) 1.29
Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res (2001) 1.28
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol (2008) 1.28
Autoimmunity and increased c-myb transcription. Science (1984) 1.27
A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry (1983) 1.26
Examination of raw beef products for the presence of Vero cytotoxin producing Escherichia coli, particularly those of serogroup O157. J Appl Bacteriol (1993) 1.26
Airways inflammation in nocturnal asthma. Am Rev Respir Dis (1991) 1.26
Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol (2001) 1.25
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav (2000) 1.25
Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. J Neurochem (2001) 1.24
Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res (1998) 1.24
Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse (1998) 1.24
Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams. Appl Environ Microbiol (2004) 1.24
Properties of Vero cytotoxin-producing Escherichia coli of human and animal origin belonging to serotypes other than O157:H7. Epidemiol Infect (1989) 1.23
Enteroaggregative Escherichia coll and outbreaks of gastroenteritis in UK. Lancet (1997) 1.23
Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol (1982) 1.21
Virulence properties of Escherichia coli strains belonging to serogroups O26, O55, O111 and O128 isolated in the United Kingdom in 1991 from patients with diarrhoea. Epidemiol Infect (1993) 1.20
Adhesion to cells in culture and plasmid profiles of enteropathogenic Escherichia coli isolated from outbreaks and sporadic cases of infant diarrhoea. J Infect (1989) 1.20
Transposition of ampicillin resistance to an enterotoxin plasmid in an Escherichia coli strain of human origin. J Bacteriol (1979) 1.20
Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse (1998) 1.20
Molecular studies of FIme resistance plasmids, particularly in epidemic Salmonella typhimurium. Mol Gen Genet (1978) 1.18
D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res (1998) 1.17
Escherichia coli O128 strains from infants with diarrhea commonly show localized adhesion and positivity in the fluorescent-actin staining test but do not hybridize with an enteropathogenic E. coli adherence factor probe. Infect Immun (1991) 1.17
Use of gene probes and adhesion tests to characterise Escherichia coli belonging to enteropathogenic serogroups isolated in the United Kingdom. J Med Microbiol (1996) 1.17
Resistance to ceftriaxone and cefotaxime in non-typhoidal Salmonella enterica in England and Wales, 1998-99. J Antimicrob Chemother (2000) 1.17
NIH conference. Systemic lupus erythematosus: insights from animal models. Ann Intern Med (1984) 1.16
Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med (1982) 1.15
Relationship between social rank and cortisol and testosterone concentrations in male cynomolgus monkeys (Macaca fascicularis). J Neuroendocrinol (2009) 1.15
Phenotypic and genetic analysis of diarrhea-associated Escherichia coli isolated from children in the United Kingdom. J Pediatr Gastroenterol Nutr (2001) 1.13
Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis (1989) 1.13
Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. Mol Cell Probes (2003) 1.11
Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine. Neuroreport (1999) 1.10